The market for new psychoactive substances is characterised by the large number of substances that have emerged, with new compounds being detected each year. On this page, you can find an overview of the drug situation for new psychoactive substances in Europe, supported by information from the EU Early Warning System on seizures and substances detected for the first time in Europe. New substances covered include synthetic and semi-synthetic cannabinoids, synthetic cathinones, new synthetic opioids and nitazenes. 

This page is part of the European Drug Report 2025, the EUDA’s annual overview of the drug situation in Europe.